ATE87465T1 - Neues arzneimittel mit antiallergischer wirkung und verzoegerter wirkstofffreigabe. - Google Patents

Neues arzneimittel mit antiallergischer wirkung und verzoegerter wirkstofffreigabe.

Info

Publication number
ATE87465T1
ATE87465T1 AT90403466T AT90403466T ATE87465T1 AT E87465 T1 ATE87465 T1 AT E87465T1 AT 90403466 T AT90403466 T AT 90403466T AT 90403466 T AT90403466 T AT 90403466T AT E87465 T1 ATE87465 T1 AT E87465T1
Authority
AT
Austria
Prior art keywords
delayed
release
treatment
active substance
gel
Prior art date
Application number
AT90403466T
Other languages
English (en)
Inventor
Henri Chibret
Original Assignee
Thea Therapeutique & Applicat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thea Therapeutique & Applicat filed Critical Thea Therapeutique & Applicat
Application granted granted Critical
Publication of ATE87465T1 publication Critical patent/ATE87465T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT90403466T 1989-12-11 1990-12-06 Neues arzneimittel mit antiallergischer wirkung und verzoegerter wirkstofffreigabe. ATE87465T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8916339A FR2655543B1 (fr) 1989-12-11 1989-12-11 Nouvelle preparation pharmaceutique anti-allergique a action prolongee, a base d'acide n-acetyl aspartyl glutamique.
EP19900403466 EP0433140B1 (de) 1989-12-11 1990-12-06 Neues Arzneimittel mit antiallergischer Wirkung und verzögerter Wirkstofffreigabe

Publications (1)

Publication Number Publication Date
ATE87465T1 true ATE87465T1 (de) 1993-04-15

Family

ID=9388356

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90403466T ATE87465T1 (de) 1989-12-11 1990-12-06 Neues arzneimittel mit antiallergischer wirkung und verzoegerter wirkstofffreigabe.

Country Status (6)

Country Link
EP (1) EP0433140B1 (de)
AT (1) ATE87465T1 (de)
DE (2) DE69001238T4 (de)
ES (1) ES2054303T3 (de)
FR (1) FR2655543B1 (de)
PT (1) PT96163B (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2546407B1 (fr) * 1983-05-24 1986-04-18 Therapeutique Applic Sa Medicament a activite anti-allergique pour administration locale a base d'acide n-acetyl(a,b)-aspartyl glutamique

Also Published As

Publication number Publication date
FR2655543B1 (fr) 1992-02-21
ES2054303T3 (es) 1994-08-01
PT96163A (pt) 1991-09-30
FR2655543A1 (fr) 1991-06-14
EP0433140B1 (de) 1993-03-31
DE69001238D1 (de) 1993-05-06
DE69001238T2 (de) 1993-10-28
PT96163B (pt) 1998-04-30
EP0433140A1 (de) 1991-06-19
DE69001238T4 (de) 1994-03-17

Similar Documents

Publication Publication Date Title
DE60138547D1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
ATE142877T1 (de) Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie
DE68902649D1 (de) Lokal anzuwendende arzneizubereitung zur behandlung von entzuendungserkrankungen.
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
ATE141502T1 (de) Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
DK0694310T3 (da) Reversibelt, termisk gelatinerende, vandbaseret, medicinsk præparat
BR9702362A (pt) Novas fomrulações lìquidas estáveis à base de paracetamol e seu modo de preparação.
NO176346C (no) Fremgangsmåte ved fremstilling av en flytende, vandig farmasöytisk blanding for öye- og/eller nasal administrasjon
CA2162306A1 (en) Use of dl-(+/-)-.alpha.-lipoic acid, d-(+)-.alpha.-lipoic acid, .alpha. lipoic acid in reduced or oxidized form or salts for treating circulatory disorders
NO975192L (no) Bicykliske aromatiske forbindelser
KR920703041A (ko) 통증을 수반하는 염증성 또는 알레르기성 질환치료에 사용되는 성분물과 그 방법
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
DE3782346D1 (de) Verwendung von chinolon und naphthyridin-antibiotika zur herstellung von ophthalmischen arzneimitteln.
BR9802796A (pt) Utilização de uma dispersão aquosa de glóbulos oleosos e processo de tratamento cosmético.
NO172043C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-2,3-butadienyl-triamioalkanderivater
DK1343472T3 (da) Thixotropisk næsespray
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
KR930019224A (ko) 유산 위험 치료제
JPS52130922A (en) Remedy for cerebral blood flow disorders containing coenzyme-q as main ingredient
NO995838L (no) Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme
EP0305277A3 (de) Verwendung von 2-Amino-6-trifluormethoxybenzthiazol zur Herstellung eines Arzneimittels zur Behandlung von Schlafstörungen und Depressionen
DE68903059D1 (de) Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten.
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
DE69001238D1 (de) Neues arzneimittel mit antiallergischer wirkung und verzoegerter wirkstofffreigabe.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time